Skip to content

GENESIS II 71421115Recalls & reported problems

Smith & Nephew, Inc. · GENESIS II OXINIUM POSTERIOR STABILIZED FEMORAL RIGHT SIZE 5 · Class 2 · Implant

All models of GENESIS II (462)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 03596010469298), received between Feb 26, 2019 and Jul 28, 2025 — classified as 6 injuries.

The most frequently reported specific device problem is “Biocompatibility” (1 report).

1 other recall cover devices cleared under the same FDA submission (K022010, K962557); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3
  • Biocompatibility1
  • Fracture1
  • Loose or Intermittent Connection1

Patient problems

  • Pain3
  • Injury2
  • Ambulation or Postural Difficulties1
  • Inadequate Osseointegration1
  • Infiltration into Tissue1
  • Insufficient Information1
  • Joint Dislocation1
  • Joint Laxity1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    DESCRIPTION SUMMARY: "IT WAS REPORTED THAT, AFTER A RIGHT TKA SURGERY WAS PERFORMED ON (B)(6) 2023, THE PATIENT UNDERWENT A REVISION SURGERY ON (B)(6) 2025 DUE TO UNKNOWN REASONS. THE FOLLOWING DEVICES WERE EXPLANTED: ONE (1) GII OXIN P/S FEM RIGHT SZ 5, ONE (1) GNS II CMT TIB SIZE 4 {} RIGHT AND ONE (1) LGN PS HIGH FLEX XLPE SZ 3-4 9MM. THE CURRENT HEALTH STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Insufficient Information; Joint Laxity; Pain

    MAUDE report 22628334 ↗
  • InjuryJan 28, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT, AFTER A TKA SURGERY PERFORMED IN (B)(6) 2022, HAD A KNEE PROSTHESIS OF AN S+N PRODUCT, SINCE THEN THE PATIENT HAVE HAD A RECURRENT PAIN. IT WAS DIAGNOSED THAT IN THE PS VARIANT A RETRO-PATELLAR GRAFT IS NEEDED. THE CURRENT HEALTH STATUS OF THE PATIENT IS UNKNOWN.

    Patient problems: Pain

    MAUDE report 21260901 ↗
  • InjuryOct 18, 2021Biocompatibility; Biocompatibility

    IT WAS REPORTED THAT, AFTER A TKR SURGERY HAD BEEN PERFORMED ON (B)(6) 2017, THE PATIENT EXPERIENCED RIGHT KNEE PAIN AND EFFUSION. THIS ADVERSE EVENT WAS TREATED BY DOING A WOUND DEBRIDEMENT ON (B)(6) 2021. DURING THE SAID PROCEDURE, THE SURGEON FOUND SIGNS OF METALLOSIS. A REVISION SURGERY WAS PERFORMED ON (B)(6) 2021 DUE TO METALLOSIS AND IMPLANT LOOSENING. DURING THIS PROCEDURE, THE FEMORAL COMPONENT, INSERT AND TIBIAL COMPONENT WERE EXPLANTED FROM THE PATIENT. CURRENTLY THE PATIENT CONDITION IS STABLE AFTER REVISION SURGERY AND IS IN THE PROCESS OF RECOVERY.

    Patient problems: Ambulation or Postural Difficulties; Inadequate Osseointegration; Infiltration into Tissue; Metal Related Pathology; Pain; Swelling/ Edema

    MAUDE report 12647305 ↗
  • InjuryDec 17, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    PRIMARY SURGERY PERFORMED ON 2016. IT WAS REPORTED THAT ON (B)(6) 2018 PATIENT FELT AN UNUSUAL SENSATION WHEN STANDING UP FROM A SEATED POSITION, THE JOINT FELT LOOSE AND HAD A CLICKING NOISE. PATIENT KNEE AND LOWER LEG STARTED TO SWELL AND PAIN INCREASED. A SCAN WAS PERFORMED AT (B)(6) HOSPITAL, WHERE THEY DIAGNOSED A BURST BAKERS CYST. IN (B)(6), PATIENT CONTACTED HER SURGEON; A JOINT X-RAY WAS PERFORMED, DOCTOR DIAGNOSED A BROKEN AND DISPLACED INSERT. A REVISION SURGERY WAS PERFORMED TO CORRECT THE ISSUE. DURING THE OPERATION IT WAS DISCOVERED THAT THE POST ON THE INSERT HAD SHEARED OFF AND THE METAL PARTS HAD WORN ON EACH OTHER LEAVING SIGNIFICANT METALLIC DEBRIS AROUND THE JOINT AND METALLOSIS. SINCE THEN, THE SECOND KNEE HAS TAKEN MUCH LONGER TO RECOVER AND PATIENT STILL NEEDS THE AID OF CRUTCHES TO WALK SIGNIFICANT DISTANCES AND REQUIRES THE NIGHTLY USE OF DICLOFENAC 3% GEL.

    Patient problems: Injury

    MAUDE report 9482275 ↗
  • InjuryApr 24, 2019Loose or Intermittent Connection; Loose or Intermittent Connection

    IT WAS REPORTED THAT A REVISION SURGERY WAS PERFORMED DUE TO A ASEPTIC LOOSENING OF TIBIA.

    Patient problems: Injury

    MAUDE report 8547110 ↗
  • InjuryFeb 26, 2019Fracture; Fracture

    IT WAS REPORTED THAT A REVISION SURGERY WAS PERFORMED DUE TO 2.5 YEARS SINCE IMPLANTATION OF THE GENESIS II PS PRIMARY KNEE REPLACEMENT. DUE TO THE INSERT PS PEG HAVING FRACTURED AND THE WHOLE POLYETHYLENE HAVING DISLOCATED THE FEMORAL COMPONENT WAS ARTICULATING ON THE TIBIA AND ERODED THE MEDIAL FEMORAL CONDYLE OF THE OXINIUM TKR COMPONENT. THE PATIENT REQUIRED A REVISION PROCEDURE TO A LEGION REVISION PROSTHESIS, MAINTAINING THE PATELLA. DURING THE REVISION PROCEDURE, IT WAS DISCOVERED THE PS POST ON THE PRIMARY INSERT HAD BROKEN AND THE KNEE SUBLUXED POSTERIORLY, WHICH IS THOUGHT TO HAVE CAUSED THE DISLOCATION OF THE INSERT FROM THE TIBIAL BASEPLATE. THE KNEE WAS X-RAYED AND SHOWN TO BE WELL LOCATED AT FOLLOW-UP OF 12-18 MONTHS FOLLOWING THE PRIMARY PROCEDURE.

    Patient problems: Joint Dislocation

    MAUDE report 8370362 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K022010, K962557. One submission often covers many models, so check the product and lot details in each record.

  • Z-0281-2025 · Oct 2, 2024 · Open, Classified
    smith&nephew GENESIS II NONPOROUS POSTERIOR STABILIZED FEMORAL COMPONENT, SIZE 5 LEFT, REF 71421015; Uncoated knee femur prosthesis, metallic

Other PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER devices

All PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page